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The influence of HLA-linked genes on anti-GBM antibody-mediated
nephritis. Thirty-nine Caucasian patients with glomerulonephritis
caused by autoantibodies to glomerular basement membrane (GBM)
were studied. They were segregated into three groups depending on
presentation: Group 1 (19 patients) were anuric or oliguric, group 2 (13
patients) had rapidly deteriorating renal function but were not oliguric,
and group 3 (seven patients) had stable renal function. The incidence of
HLA-DR2 was greatly increased; it was present in 34 of 38 patients in
whom DR antigens were identified compared to 43 of 154 controls (Pc
= 0.63 x l0, relative risk 36, etiological fraction 0.86). The incidence
of HLA-B7 was also increased; present in 23 of 39 patients and 43 of 193
controls (Pc = 0.26 x l0, relative risk 5.0, etiological fraction 0.43).
These data were analyzed for a third order association between
HLA-DR2, HLA-B7, and anti-GBM disease. Such an association was
probable for patients in group 1 (P = 0.27 >< 10-6), likely for those in
group 2 (P = 0.024) but unlikely for patients in group 3 (P = 0.62)
suggesting HLA-B7-associated genes influence severity. Clinical results
from a subset of the patients referred directly on presentation showed
that patients who inherited HLA-B7 together with DR2 had significantly
higher plasma creatinines, a greater proportion of glomeruli surrounded
by crescents and a worse prognosis. Despite this there was little
difference in severity of their lung disease.
Influence des genes lies a HLA sur Ia sévérité de Ia nephrite médiée par
un anticorps anti-GMB. Trente-neuf malades blancs atteints de
glomerulonéphrite due a des anticorps dirigés contre Ia membrane
basale glomerulaire (GBM) ont été Ctudiés. Ils ant été divisés en trois
groupes en function du tableau: ceux du groupe I (19 malades) ëtaient
anuriques ou oliguriques, ceux du groupe 2 (13 malades) avaient une
fonction rénale se détCriorant rapidement mais n'étaient pas
oliguriques, et ceux du groupe 3 (sept malades) avaient une fonction
rénale stable. L'incidence de HLA-DR2 était tres augmentée; il était
present chez 34 des 38 malades chez qui les antigênes DR avaient été
identifies, par rapport a 43 de 154 contrôles (Pc = 0,63 x 10-8, risque
relatif 36, fraction etiologique 0,86). L'incidence de HLA-B7 Ctait
egalement augmentée; il était present chez 23 des 39 malades et 43 de
193 contrôles (Pc = 0,26 x l0, risque relatif 5,0, fraction etiologique
0,43). Ces données ont été analysees pour une association du troisiCme
ordre entre HLA-DR2, HLA-B7, et Ia maladie anti-GBM. LJne telle
association était probable pour les malades du groupe I (P 0,27 x
10), possible pour ceux du groupe 2 (P = 0,024), mais improbable
pour ceux du groupe 3 (P = 0,62), suggerant que les genes associés a
HLA-B7 influencent Ia sévérité. Les résultats cliniques dun sous-
groupe de malades adressCs directement au debut ant montré que ceux
qui avaient hérité de HLA-B7 et de DR2 avaient des crCatininémies?
significativement plus Clvées, une plus grande proportion de glomerules
entourés de croissants et un pronostic plus mauvais. Malgré cela, ii y
avait peu de difference de sévérité de leur maladie pulmonaire.
Autoantibodies to glomerular basement membrane (GBM)
are an unusual but important cause of glomerulonephritis [11.
Typically, patients with this disease present with focal necrot-
izing glomerulonephritis which, when untreated, progresses
rapidly to renal failure [2, 3]. Less commonly the patients have
more indolent disease and only develop renal failure after many
years [3, 4]. Two-thirds to three-quarters of the patients also
have pulmonary hemorrhage (Goodpasture syndrome).
Although it is not known why patients develop autoantibod-
ies to the GBM, there is strong evidence for a genetical
predisposition. In a previous study we found the incidence of
the HLA antigen DR2 to be greatly increased [5], as to a lesser
extent was HLA-B7. However, the latter finding was difficult to
interpret because HLA-B7 and DR2 are known to be in linkage
disequilibrium in healthy Caucasoid populations.
Linkage disequilibrium occurs when alleles at separate ge-
netical loci are inherited together more often than expected
from their individual gene frequencies; its strength is measured
by the difference between observed and expected incidences.
Numerous examples of strong linkage disequilibrium are found
within the HLA complex; for instance B7 is inherited together
with DR2 four times more often than expected [6]. The reasons
for linkage disequilibrium are uncertain but there are compel-
ling arguments that, in some circumstances, the disequilibrium
is maintained because it confers a selective advantage to the
host. If this were true for the HLA complex, that advantage
might be due to more effective immunoinflammatory responses.
The present genetical and functional study of a larger group
of patients with anti-GBM disease was undertaken in an attempt
to confirm the strong association between anti-GBM antibody-
mediated nephritis and HLA-DR2, to see whether DR2 or the
putative haplotype DR2,B7 was associated with the anti-GBM
auto-antibody response; and finally to establish whether inheri-
tance of B7 together with DR2 influenced the expression of
injury in anti-GBM disease once established.
Methods
Patients. We studied 39 Caucasian patients with anti-GBM
disease who were referred to Hammersmith Hospital, London,
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United Kingdom, for treatment at various stages of their illness.
All 39 had glomerulonephritis which was accompanied by
pulmonary hemorrhage in 32. The diagnosis was established by
characteristic linear staining of the GBM on immuriofluorescent
preparations of renal biopsy specimens (36 of 36) and by
detection of circulating anti-GBM antibodies by radio-
immunoassay (39 of 39). A subgroup consisting of all the
patients with HLA-DR2 referred to Hammersmith immediately
after they presented were treated in a uniform manner [71. They
were studied in more detail to assess the effect of HLA-B7 on
the expression of their disease. In these patients standard
criteria [8] including the measurement of single breath transfer
factor corrected for alveolar volumes (kCO) [9] were used to
assess the presence of pulmonary hemorrhage.
Glomerulonephritis. Renal biopsy specimens were processed
in standard fashion and the proportion of glomeruli surrounded
by crescents was calculated. Renal function was assessed by
serial measurements of plasma creatinine, using a standard auto
analyzer technique. The patients were divided into three groups
depending on their clinical presentation: Group 1 (19 patients)
were oliguric or anuric and required dialysis for renal failure;
group 2 (13 patients) had rapidly deteriorating renal function but
were not oliguric and were not dialyzed; and group 3(7 patients)
had stable renal function for at least 1 month before presentation.
Anti-GBM antibodies. Anti-GBM antibodies were measured
by solid-phase radioimmunoassay [10]. This assay detects IgG
antibodies that bind to collagenase digests of GBM. The results
are expressed as percentage binding of reference positive serum
and values greater than 12% are positive.
HLA typing. HLA typing was performed by standard
microcytotoxicity assays [11]. Frequencies of A, B, and C
antigens in the patients were compared to those of a sample of
193 local Caucasoid controls and the DR antigens to a subset of
153 of these controls. Allotypes of the alternative pathway
complement protein, factor B, which are encoded within the
HLA complex, were determined by immunoelectrophoresis
[121 in 29 patients.
Statistical analysis. The significance of differences in the
frequencies of HLA antigens in control and disease samples
were assessed from contingency tables by x2 after correction
for the number of comparisons made. The strength of associa-
tion was estimated by both relative risk (RR) [13] and the
etiological fraction (EF) [13]. The relative risk is a simple
measure of the increased risk of developing the disease con-
ferred by a marker, in this case, an HLA antigen. By contrast
the etiological fraction is a measure of how much of the disease
is due to the disease-associated marker and is identical to the
population attributable risk [14], a standard measure in epi-
demiology. The advantages of the EF are twofold: Unlike the
RR, it is independent of the frequency of the marker in control
samples and thus can be used to compare directly the strengths
of different markers in different diseases. Secondly, provided
that the mode of inheritance is known, it can be used to infer the
degree of linkage disequilibrium between disease susceptibility
and marker genes [15]. Where the association between a disease
and a particular antigen is absent, the etiological fraction is zero
while complete association produces a value of 1. Comparison
between indices of severity of anti-GBM nephritis in groups of
patients inheriting HLA-DR2 with and without B7 was made by
Wilcoxon rank sum test or Fishers exact test as appropriate.
Assessment of third order association between HLA-DR2, B7
and anti-GBM disease. There are considerable problems in
using results from population samples to assess the strength and
probable significance of associations between alleles at three
linked genetical loci. The principal difficulty is to distinguish the
effect of linkage disequilibrium between the alleles at all three
loci (a third order association) from the hitchhiking effect of
separate disequilibria between the alleles at one locus and
alleles at the other two. Linkage disequilibrium () is defined as
the inheritance together of alleles at separate but linked loci
more often than expected by chance. Thus, linkage disequilib-
rium between two alleles, A and B, is represented by:
AB = AB observed — AB expected
= pAB pApB
(1)
(2)
where pA, pB, and pAB are the frequencies of A, B, and AB,
respectively. This concept can easily be extended to three or
more linked loci, but estimation becomes progressively more
difficult because it must take account of individual linkage
disequilibria between alleles at each pair of loci [16]. Thus,
using the same notation for alleles at our original two loci A and
B and an allele at disease susceptibility locus (S):
zABS = pABS — pApBpS — [AB + AS + LBS] (3)
This equation can be solved when the frequencies of alleles at
all three loci are known. It follows that when ABS is zero,
there is no residual linkage disequilibrium and the conjoint
frequency of ABS (pABS) is explained by the frequencies of A,
B, and S at their individual disequilibria. Unfortunately, the
equation is insoluble for HLA haplotype disease associations
because the frequency of the disease susceptibility gene cannot
be ascertained in the general population [17]. Porta and
McHugh [18] re-expressed the disequilibrium equation in terms
of the unknown value (pS) to derive a statistic where:
SABS = LABS
pS
(4)
This equation can be solved and the standard error of any
estimated value for 5 can be calculated and so the probability
that SABS differs from zero can also be determined. It follows
that when SABS is not zero then ABS will also differ from zero
and the observed frequency of pABS in the disease sample can
be explained only by residual linkage disequilibrium. In this
study values for ABS were calculated on a MSI 6800 mi-
croprocessor using a program written in BASIC.
Results
HLA typing. At least one HLA antigen was identified at A
and B loci in all 39 patients and at the DR locus in 38 of 39
patients. There was an obvious increase in the incidence of
HLA-DR2 in patients with anti-GBM disease (Table 1); it was
present in 34 of 38 (89%) patients compared to 30 of 153 (19%)
healthy controls. The difference is highly significant (Pc = 1,63
x l0). Inheritance of HLA-DR2 confers a relative risk of 36
and an etiological fraction of 0.86. Thirty-one of the 34 patients
with HLA-DR2 were heterozygous at this locus. Thus, the
effect associated with DR2 behaves in an autosomal dominant
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Patients
%
Controls
% x2 Pca
Relative
riskb
Etiological
fractionc
DR2 34/38 (89.5) 30/157 (19.1) 68.7 0.63 x 108 36 0.86
B7 23/39 (59.0) 43/193 (22.3) 26.5 0.23 x l0 5 0.47
A3 17/39 (43.6) 57/193 (29.3) 2.9 0.53 1.8 0.22
Patients with antigen Controls without antigenRelative risk = . . . xPatients without antigen Controls with antigen
The etiological fraction was calculated from the formula:
Patients 4 2 4 13 4 0 3 0 4
(Number = 39)
Controls 3 4 4 8 1 3 7 0 0
(Number = 30)
fashion. The frequencies of the second DR antigens were the
same in patients and controls who inherited HLA-DR2 (Table
2). The incidence of HLA-B7 was also increased (Table 1); it
was present in 23 of 39 (59%) patients compared to 43 of 193
(22%) controls (Pc = 0.26 x i0, relative risk 5, etiological
fraction 0.47). Next we tested whether this finding was explic-
able completely by the known linkage disequilibrium between
HLA-B7 and DR2 in Caucasoid populations.
Third order association between HLA-DR2, B7 and anti-
GBM disease. The proportion of people with HLA-DR2 who
also inherited B7 was similar in total patient (23 of 34, 67.7%)
and control (19 of 30, 62.3%) samples: However, none of the
patients inherited B7 without DR2 whereas 11 control subjects
did (Table 3). When results from the three patient groups
categorized at presentation were considered separately, there
was a progressive decrease in the proportion of patients with
DR2 who also have B7 from group 1 (anuric) to group 2
(progressive nephritis) to group 3 (stable nephritis) (Table 3).
These data were analyzed for a third order association between
the putative haplotype HLA-DR2, B7 and anti-GBM disease
susceptibility gene. Because 33 of the 36 patients were heterozy-
gous at the DR locus, only the values for the statistic 8
calculated on the assumption that the putative disease suscep-
tibility gene displays dominant inheritance are shown. The 8
value (± SE) for the total patient group was 0.375 0.084
indicative of a high probability (P = 4 X 10) of a real third
order association between the HLA antigen DR2, B7 and
anti-GBM disease (Fig. 1). When calculated separately for the
three patient groups, 8 values were group 1, 0.551 0.047;
group 2, 0.280 0.141; and group 3, 0.044 0.150, which
indicate that the strength of the association between DR2, B7,
Table 1. Frequencies of HLA antigens DR2, B7 and A3 in patient and
control samples
Table 3. Frequencies with which HLA-B7 is inherited with HLA-DR2
in patients with anti-GBM disease and in controls; group 1 patients
were oliguric on presentation, group 2 had rapidly deteriorating renal
function but were not oliguric, and group 3 had stable renal function
a Pc is the P value corrected for the number of comparisons made.
b The relative risk was calculated by the formula:
All
HLAtype
Controls
(N=153) patients(N=38) Group(N=l9)1 Group(N=12)2 Group 3(N=7)
DR2 (+) B7 (+) 19 23 15 6 2
DR2(+)B7(—) 11 11 3 4 4
DR2(—)B7(+) 11 0 0 0 0
DR2(—)B7(—) 112 4 1 2 1
Patients with antigen (Relative risk — 1)Etiological fraction = . xTotal number of patients Relative risk
Table 2. The frequency is of second HLA-DR antigens in those
patients and controls who inherited HLA-DR2
None DR1 DR3 DR4 DR5 DR6 DR7 DR8 DR9
.0
at
0.70 -
a
r-.
-
Q 0.50 -
at
-JI
0
. 0.30 -
'a
U) -0
0.10 -
All Pts. Gp. 1 Gp. 2 Gp. 3
I
-
0.4 x 1O 0.27 x 10 0.024 0.62
Probability of a third order association
Fig. 1. 8 Statistic SE for a third order association between HLA-DR2,
HLA-B7, and anti-GBM antibodies. The values were calculated on
the assumption of a dominant inheritance of the disease susceptibility
gene. The 8 values significantly different from zero are indicative of a
third order association and the probability of such an association is
given below. Groups 1, 2, and 3 refer, respectively, to patients who
were at presentation, oliguric, those with rapidly deteriorating renal
function without oliguria, and those who had stable renal function.
and anti-GBM disease was greatest in patients who were anuric
at presentation and that a third order association was unlikely in
patients who present with stable glomerulonephritis.
It can be inferred from these results that HLA-B7 is associ-
ated with increased severity of anti-GBM nephritis rather than
its genesis. To test this proposition directly, we studied clinical
and morphological indices of severity of glomerulonephritis
together with other aspects of their disease in HLA-DR2 positive
patients referred to Hammersmith directly on presentation.
Clinical expression of anti-GBM disease. Twenty-seven pa-
tients with HLA-DR2 were referred directly to us; 18 of these
inherited HLA-B7 while nine did not. Individual clinical details
of these patients are given in Table 4. Age and sex distributions
were the same in groups of patients segregated by whether or
not they inherited HLA-B7. Similarly, there was no significant
difference between the groups in the duration of symptoms
before presentation which were 3.44 2.95 months (mean
SD) and 2.53 1.89 months, respectively.
However, renal function was appreciably worse at presenta-
tion in patients with DR2 and B7; they were more likely to
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Table 4. Clinical details of 27 HLA-DR2 positive patients with anti-GBM disease referred directly on presentation
a Mean kCO of patients with Goodpasture syndrome.
present with oliguria or anuria (Table 5, P < 0.02, Fishers exact
test). Measurements of their plasma creatinine were signifi-
cantly higher (Fig. 2, p < 0.02, Wilcoxon rank sum test), and a
significantly greater proportion of glomeruli in renal biopsy
specimens were surrounded by crescents (Fig. 3, p < 0.01,
Wilcoxon rank sum test). Prognosis of the patients was worse
after standard treatment with immunosuppression and plasma
exchange; II out of 18 are dead or on dialysis compared to one
of nine with DR2 only (P < 0.02, Fishers exact test).
Differences in the intensity of pulmonary injury were less
obvious. A greater proportion of patients without B7 had
pulmonary hemorrhage; nine out of nine compared to 11 of 18
with both antigens (P < 0.04, Fishers exact test). This differ-
ence is difficult to interpret genetically because of the known
influence of cigarette smoking on pulmonary hemorrhage in this
disease [8]. All patients with pulmonary hemorrhage in this
Table 5. Clinical presentation of patients with anti-GBM disease who
inherited HLA-DR2 and were referred patients directly on
presentation; the patients are categorized by whether they also
inherited HLA-B7
Patients Presentation
Progressive Stable
HLA-B7 Oliguric glomerulonephritis glomerulonephritis
DR2(+),B7(+) 11 5 2
DR2 (+), B7 (—) 1 4 4
series were cigarette smokers whereas nonsmokers had no
evidence of lung disease. Furthermore, the episodic nature of
pulmonary hemorrhage complicates interpretation of its sever-
ity. There was no significant difference between the two groups
Sex Age
(Patients with HLA DR2 + B7) Symptoms, duration
Plasma
creatinine
ji.moles/liter
Pulmonary kCO, mmoles/min/kpa
hemorrhage Presentation Maximum
I F 7 Diarrhea (1/52); oliguria 1200 — ND ND
2 F 20 Hemoptysis (2/52); oliguria 1120 + 1.3 2.97
3 M 55 Fever, diarrhea (1/12); oliguria 1100 — 1.21 1.85
4 F 22 Hemoptysis (2/52); oliguria 1630 + 1.9 18.5
5 F 22 Hemoptysis (2/12); hematuria (1/52)
oliguria
1936 + 2.78 4.73
6 F 22 Episodic hemotpysis (8/12); frothy
urine (3/12) oliguria
1160 + 3.08 3.08
7 F 20 Malaise, hemoptysis (3/12); vomiting
5/7, oliguria
1620 + 2.47 4.7
8 M 26 Episodic hemoptysis (11/12);
microhematuria (6/12)
1000 + 1.72 1.79
9 M 55 Fever, nausea (3/52) 515 — 1.44 1.44
10 F 27 Hemoptysis (3/12); myalgia (1/52);
oliguria
1775 + 4.2 5.5
11 M 55 Hemoptysis (4/12) 520 + 1.23 1.23
12 F 50 Hemoptysis (2/12); macrohematuria
(1/52)
290 + 1.50 4.01
13 F 20 Hemoptysis (8/12); edema (6/12) 200 + 1.26 1.58
14 M 58 Anorexia, vomiting (6/52) 238 — 1.03 1.53
15 F 27 Malaise (1/12); microhematuria (1/7) 600 — 1.67 1.79
16 M 23 Hemoptysis (3/12), microhematuria
(2/52)
350 + 2.90 2.90
17 M 72 Malaise (5/12); microhematuria (1/52)
oliguria
1598 0.49 0.88
18 F 67 Malaise (6/12); myalgia (1/52); oliguria 740 1.31 2.14
M:F 7:11 36 19 Mean duration of symptoms 3.4 3 977 555 11/18
19 F 65 Diarrhea (2/12); vomiting (3/52); 1220 +
oliguria
20 M 24 Hemoptysis (2/12) 590 +
21 F 45 Hemoptysis (3/52) 475 +
22 M 17 Hemoptysis (2/12); macrohematuria
(1/52)
154 +
23 F 20 Hemoptysis (1/12); microhematuria
(2/52)
95 +
24 M 38 Malaise (4/12); frothy urine (2/12) 234 +
25 F 62 Frothy urine (5/12); vomiting (1/12) 822 +
26 M 19 Hemoptysis (4/12) 154 +
27 M 17 Hemoptysis (2/12); dyspnea (2/52) 95 +
1.44 1.49
2.41
1.39
1.75
2.41
2.74
4.56
M:F 5:4 34 19 Mean duration of symptoms 2.5 1.4
2.3 0.99" 4.64 4.58"
9/9 1.86 0.40 2.60 0.81
2.3 2.5
1.8
1.61
1.55
2.46
427 368
2.76
2.76
1.73
2.46
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Proportion of glomeruli by crescents, %
Fig. 3. Percentage of glomeruli sur,-ounded by crescents in patients with
anti-GBM disease. The patients are classified by whether or not they
inherited (LI) or did not inherit (U) HLA B7 together with HLA DR2.
in the magnitude kCO on admission of those with Goodpasture
syndrome. However, comparisons of kCO at this stage, (2.2
0.99; mean SD vs. 1.80 0.4) and when the kCO was
maximal (4.64 4.6 vs. 2.60 0.81) revealed a tendency for
patients with both HLA-DR2 and B7 to have higher kCOs
(0.075 > P > 0.05, Wilcoxon rank sum test).
There were no significant differences in the magnitude of
anti-GBM antibody titers at presentation (Fig. 4) or in the
distribution of properdin Factor B allotypes.
Discussion
There are numerous reports of associations between HLA
antigens and auto-immune diseases; but anti-GBM disease
remains a uniquely good model for study. Because it is a disease
defined precisely by possession of autoantibodies to the GBM,
the pathogenecity of these autoantihodies has been established
[191; the autoantibody can be measured quantitatively in serum
[10, 20], and the consequent injury can be accurately assessed
morphologically and functionally. The interest of this study of
anti-GBM disease is threefold: First, it confirms that HLA-DR2
is associated with susceptibility to anti-GBM antibody synthe-
sis. Secondly, it demonstrates that susceptiblity is associated
with DR2 itself rather than the putative haplotype HLA-DR2,
B7. Thirdly, because it demonstrates that HLA-B7, normally in
linkage disequilibrium with DR2, is associated with increased
severity of the resultant glomerulonephritis.
Since our original report [5], Pen et al [21], in Australia. have
reported that HLA-DR2 was present in seven of eight patients
with anti-GBM disease, whereas Garovoy [22], in the United
States has reported a lower incidence; 23 of 46 patients. It is
impossible to say why this result from America should differ
from the other two reports as data about racial or geographical
origins of the patients have yet to be provided. However, over
the past 8 years in the United Kingdom we have consistently
found that nearly 90% of patients with anti-GBM disease
referred to us have HLA-DR2.
This study of additonal patients with more stringent analysis
has shown that the effect associated with HLA-DR2 behaves in
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Fig. 4. Anti-GBM antibody titers in 27 DR2 positive patients with
anti-GBM disease. The results together with median and 95% nonpara-
metric confidence intervals are classified by whether or not the patients
also inherited HLA B7. The difference between the groups is not
signficant (Wilcoxon rank sum test).
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Mendelian dominant fashion. In this circumstance the etiologi-
cal fraction provides a direct measure of the degree of linkage
disequilibrium between HLA-DR2 and the putative disease
susceptibility gene [151. In our case this is just under 90% of the
maximal value attainable. Both these observations strengthen
our original hypothesis that HLA-DR2, or a separate but tightly
linked immune response gene-associated antigen, is involved in
the generation of anti-GBM autoantibodies.
Nevertheless, even if HLA-DR2 does act in this way most
poeple with this antigen remain healthy. The probable explana-
tion for this is that genes at other independently segregating
genetical loci also determine whether anti-GBM autoantibody
synthesis can proceed. This is the case in mercuric chloride-
induced autoimmune anti-GBM antibody-mediated nephritis in
rats. In this disease Druet et a! [23] have shown that the
response to restricted rats with the Brown-Norway histo-
compatibility type but that one or two genes at unlinked loci are
also required. Similarly Neilson et al [24] have shown the
interstitial nephritis associated with autoantibodies to tubular
basement membrane in mice to be restricted by the MHC as
well as other genes. Thus, in both models not all animals with
appropriate MHC antigens develop the disease. Lately, we
have identified a second genetical locus associated with human
anti-GBM antibodies; 54% of a sample of patients with anti-
GBM disease had the immunoglobulin heavy chain allotype
IgGl Gm2 compared to 19% of healthy controls (P = 1.5 x
io Fishers exact test) [251.
The second important observation is that the development of
anti-GBM autoantibodies appears to be associated directly with
FILA-DR2 rather than the putative haplotype HLA-B7, DR2.
This was strongly suggested by the use of Porta and McHugh's
[181 method to search for a third order association between the
HLA-DR2, B7, and anti-GBM disease. These studies showed
strong evidence for residual linkage disequilibrium in patients
who were anuric at presentation but that such a disequilibrium
was unlikely for patients presenting with indolent nephritis.
This suggested that the frequency of HLA-B7, significantly
increased in patients with anti-GBM disease, cannot be ex-
plained by the involvement of B7 in susceptibility to anti-GBM
antibodies or by its known linkage disequilibrium to HLA-DR2;
rather than HLA-B7 is associated with an influence on the
severity of anti-GBM nephritis. This conclusion is supported by
observations on patients referred to us directly as they pre-
sented. Comparison of various functional and morphological
indices showed that patients inheriting HLA-B7 together with
DR2 had more severe nephritis on presentation. There was a
trend to more severe pulmonary disease, but this was much less
obvious. This is not surprising as pulmonary hemorrhage as-
sociated with anit-GBM antibodies is much more episodic than
the nephritis, and profoundly influenced by environmental
factors such as cigarette smoking [8], intercurrent infection
[26], and fluid overload [26]. These environmental influences
might be expected to overwhelm a genetical contributions to
severity.
There are two possible genetical interpretations of these
results: First, different susceptibility genes could be associated
with HLA-DR2-bearing haplotypes with and without B7, and
that the DR2, B7 haplotype associated gene codes for more
severe nephritis; or secondly, there is a single susceptibility
gene associated with HLA-DR2 but that its expression is
influenced by the presence of HLA-B7 or by genes linked to it.
Presently, these hypotheses cannot be distinguished by formal
genetical analysis but the experimental precedent of autoim-
mune thyroiditis in mice [27] makes the first explanation much
more likely. Susceptibility for this disease is encoded by genes
in the K or 1A regions of the mouse MHC while the severity of
the resultant disease is separately encoded by genes in the D
region. In this model, as in our patients, the effect appears to be
independent of the autoantibody titer, but there is no informa-
tion in either case about the affinity of the antibodies involved,
their rates of synthesis, or the contribution of T cell-mediated
immunity, all of which could have powerful effects on injury.
It is interesting that separate HLA-linked effects have also
been reported in multiple sclerosis and optic neuritis, another
disease associated with HLA-DR2 [28]. The probability of
progressing to multiple sclerosis after an attack of optic neuritis
is significantly greater in patients with HLA-DR2 who are
homozygous for the factor B allotype BFS, encoded within the
MHC, [291 than in the heterozygotes. However, in our patients
factor B allotypes had no perceptible influence. Previously,
there have been tentative suggestions of separate HLA-linked
association with susceptibility and progression of two other
types of glomerulonephritis, mesangial IgA (Berger) disease
[30] and membranous nephropathy [31], but in neither case is
the pathogenesis of the glomerulonephritis understood nor are
the results clear.
Presently, we can only speculate on the mechanism by which
HLA-B7 is associated with increased severity of anti-GBM
nephritis. We do not know whether DR2 and B7 need to be
inherited on the same chromosome (that is, as a haplotype) for
their effect, but this could be resolved by family studies.
Finally, it is of particular interest that the products of two genes
held in linkage disequilibrium in the normal population appear
to interact to affect the intensity of autoimmune injury. This
would be predicted by the hypothesis that linkage disequilib-
rium between HLA-B7 and DR 2 is maintained in the popula-
tion because it results in more effective immuno-inflammatory
responses. Normally this would confer better protection against
infection but in the special circumstances of autoimmune dis-
ease it would be associated with more severe injury.
In conclusion, we have confirmed the very strong association
between HLA-DR2 and anti-GBM disease and we have shown
that nephritis is worse in patients with HLA-B7 and DR2. These
facts must be considered in any controlled trials of treatment for
this disease.
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